Alleva, F.R., Haberman, B.H., Slaughter, L.J. and Balazs, T. (1981). Muscular degeneration of rats after post-natal treatment with 6-Mercaptopurine. Drug Chem. Toxicol. 4:133-146.
2.
Asatoor, A.M. and Armstrong, M.D. (1967). 3-Methylhistidine, a component of action. Biochem. Biophys. Res. Comm. 26:168-174.
3.
Bianchi, C.P. (1973). Aspects of calcium metabolism and respiration in skeletal muscle. In: Pharmacology of Thermoregulation, pp 85-88. Basel: Kragel.
4.
Bianchi, C.P., Jaweed, M.M., Alleva, F.R. and Balazs, T. (1986). Increased Ca load-atrophied and non-atrophied skeletal muscles from 6-mercaptopurine-treated rats. Toxicology and Industrial Health2(2) pp 99-104.
5.
Bird, J.W.C., Carter, J.H., Triemer, R.E., Brook, R.M. and Spanier, A.M. (1980). Proteinase in cardiac and skeletal muscle. Fed. Proc. 39:20-25.
6.
Corbett, A.J., Grigg, R.C. and Moxley, R.T. (1982). Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic muscular atrophy. Neurology (NY)32:550-552.
7.
Ferraro, T.N. and Hare, T.A. (1984). Triple column ion exchange physiological amino acid analysis with fluorescent detection: Baseline characterization of human cerebrospinal fluid. Anal. Biochem. 143:82-94.
8.
Goldberg, A.L., Griffin, G.E. and Dice, J.F. (1977). Regulation of protein turnover in normal and dystrophic muscle. In: Pathogenesis of Human Muscular Dystrophies, Rowland, L.P. (ed), pp. 376-385. Amsterdam: Excerpta Medica.
9.
Grigg, R.C., Moxley, R.T. and Forbes, G.B. (1980). 3-Methylhistidine excretion in myotonic dystrophy . Neurology (NY)30:1262-1267.
10.
Haverberg, L.N., Omstedt, P.T., Munro, M.H. and Young, V.R. (1975). N-3-Methylhistidine content of mixed proteins in various rat tissues. Biochem. Biophys. Acta405:67-71.
11.
Herbison, G.J., Jaweed, M.M. and Ditunno, J.F. (1979). Muscle atrophy following denervation, casting, inflammation and tenotomy. Arch. Phys. Med. Rehabil. 60:401-404.
12.
Jaweed, M.M., Gordon, E.E., Herbison, G.J. and Kowalski, K. (1974). Endurance and strengthening exercise adaptations. I. Protein changes in skeletal muscles. Arch. Phys. Med. Rehabil . 55:513-517.
13.
Jaweed, M.M., Herbison, G.J. and Ditunno, J.F. (1982). Influence of activity and inactivity on 14C-leucine incorporation in reinnervated rat gastrocnemius. Arch. Phys. Med. Rehabil. 63:589-599.
14.
Jaweed, M.M., Bianchi, C.P., Narayan, S., Alleva, F.R. and Balazs, T. (1983a). Electrolyte changes in 6-Mercaptopurine treated rat skeletal muscles. Pharmacologist25:212.
15.
Jaweed, M.M., Butler, T.M., Alleva, F.R. and Balazs, T. (1983b). Changes in high energy phosphates in 6-Mercaptopurine treated rats. Toxicol. Lett. 18:87.
16.
Jaweed, M.M., Alleva, F.R., Herbison, G.J., Ditunno, J.F. and Balazs, T. (1985). Muscle atrophy and histopathology of the soleus in 6-Mercaptopurine treated rats. Exp. Mol. Pathol. 43:74-81.
17.
Johnson, P., Harris, C.I. and Perry, S.V. (1967). 3-Methylhistidine in actin and other muscle proteins . Biochem. J. 105:361-370.
18.
Kugelberg, E. (1973). Properties of the rat hind limb motor units. In: New Developments in Electromyography and clinical neurophysciology , Desmedt, J.E. (ed), Vol. 1, pp. 2-13.
19.
Li, J.B. and Wassner, S.J. (1981). Muscle degradation in uremia: 3-Methylhistidine release in fed and fasted rats. Kidney Int. 20:231-235.
20.
McKearn, R.O., Halliday, D., Purkiss, P. and Royston, P. (1979). 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease. J. Neurol. Psychiat . 42:536-541.
21.
Millward, D.J., Bates, P.C., Grimble, G.K., Brown, G. et al. (1980). Quantitative importance of non-skeletal muscle N-3-methylhistidine in urine. Biochem. J. 190:225-228.
22.
Mussini, E., Cornelio, F., Columbo, L., Deponte, G. et al. (1984). Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-Methylhistidine in the urine . Muscle & Nerve7:388-391.
23.
Pennington, R.J. (1977). Proteinases of muscle. In: Proteinases in mammalian cells and tissue, pp. 516-543. Amsterdam: North Holland.
24.
Rothig, H.-J., Bernhardt, W. and Aftig, E.-G. (1984). Excretion of total and muscular N-methylhistidine and creatine in muscle diseases. Muscle & Nerve7:374-379.
25.
Seashore, J.H., Hurzar, G.B. and Davis, E.M. (1980). Urinary 3-Methylhistidine excretion and nitrogen balance in healthy and stressed premature infants. J. Ped. Surg. 15:400-404.
26.
Susheela, A.K., Hudgron, P. and Walton, J.N. (1969). Histologic and histochemical studies of experimentally induced degeneration and regeneration in normal and dystrophic mouse muscle . J. Neurol. Sci. 9:423-442.
27.
Young, V.R. and Munro, H.N. (1978). NT-methylhistidine (3-Methylhistidine) and muscle protein turnover: An overview. Fed. Proc. 37:2291-2300.
